Remedium Lifecare Ltd Split

15.99
(-0.25%)
Jul 23, 2024|03:50:00 PM

Remedium Life CORPORATE ACTIONS

24/07/2023calendar-icon
23/07/2024calendar-icon
PurposeAnnouncement DateSplit DateRecord DateFace Value (before split)Face Value (after split)
Split8 Jan 202423 Feb 202423 Feb 202451
Outcome for Outcome Of The Board Meeting Sub-division (stock split) of every 1(one) equity share of face value Rs. 5/- each into 5 (five) equity share of face value of Re.1/- Company has approved Record date for Stock Split (Sub-division) of equity share of Rs.5/- per equity share to Re.1/- per equity share through Postal Ballot. (As per BSE Announcement Dated on 12/02/2024) Trading Members of the Exchange are hereby informed that REMEDIUM LIFECARE LTD, has fixed Record Date for the purpose of Sub-Division of the Equity Shares of the Company :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE REMEDIUM LIFECARE LTD (539561) RECORD DATE 23/02/2024 PURPOSE Subdivision of existing Equity Shares from One Equity Share of Rs.5/- each into Five Equity Shares of Re.1 /- each. SUB-DIVIDED PAID-UP VALUE Re.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 23/02/2024 DR-724/2023-2024 Note: - i. ISIN No. INE549S01028 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 23/02/2024. ii. The new ISIN Number for Re. 1/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 13.02.2024) Company has approved Record date for Stock Split (Sub-division) of equity share of Rs.5/- per equity share to Re.1/- per equity share through Postal Ballot. (As Per BSE Announcement Dated on 12/02/2024) With reference to the captioned subject, we would like to inform you that Company has received NEW ISIN from CDSL and NSDL pursuant to sub division/ stock split of Face Value of the Equity Shares from Rs.5/- each to Re.1/- each. Please note New ISIN- INE54S01036. With reference to the captioned subject, we would like to inform you that Remedium Lifecare Limited has received NEW ISIN from CDSL and NSDL pursuant to Subdivision / Stock Split of Face Value of the Equity shares from Rs. 5/- each to Re.1- each. Please note that the New ISIN of the Company is INE549S01036 and Sub division/ Stock Split of Equity Shares will take effect under New ISIN. (As Per BSE Announcement Dated on 19/02/2024) In Continuation of Notice No. 20240213-7 dated February 13,2024, Trading Members of the Exchange are hereby informed that the New ISIN number for the Sub-Divided Equity Shares of the Company will be as under: - Company Name & Scrip Code REMEDIUM LIFECARE LTD (539561) New ISIN No. INE549S01036 Remarks Sub-division of Equity Shares from Rs.5/- to Re.1/- The new ISIN number given above, for Equity Shares of Re.1/- each of the Company shall be effective for trades done on and from the Ex-Date i.e. 23-02-2024 (DR- 724/2023-2024) (As Per BSE Notice Dated on 21.02.2024)
Split23 Jun 20231 Sep 20231 Sep 2023105
Remedium Lifecare Ltd has informed BSE that the Board of Directors of the Company at their meeting held on 23/06/2023 ,inter alia, had considered and approved the: 1. Sub-division of Shares/ Stock Split of the Company. Subject to the approval of the members in the Annual General Meeting and appropriate authorities, the Board has considered, approved and recommended for Sub-division of Companys 1 (One) Equity Share of Face Value of Rs. 10/- each into 2 (Two) Equity Shares of Face Value of Rs. 5/- each held as on the Record date which shall be decided for this purpose. The Company has fixed Friday, September 01, 2023 as the Record Date for the purpose of ascertaining the names of the Shareholders who would be entitled to receive 2(Two) Equity Shares of the Face Value of Rs. 5/-each for every 1 (One) Equity Share of Face Value of Rs.10/- each held by them. (As Per BSE Announcement Dated on 08/08/2023) Trading Members of the Exchange are hereby informed that REMEDIUM LIFECARE LTD, has fixed Record Date for the purpose of Sub-Division of the Equity Shares of the Company :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE REMEDIUM LIFECARE LTD (539561) RECORD DATE 01.09.2023 PURPOSE Subdivision of existing Equity Shares from One Equity Share of Rs.10/- each into Two Equity Shares of Rs 5/- each. SUB-DIVIDED PAID-UP VALUE Rs.5/- SUB-DIVIDED PAID-UP VALUE W.E.F. 01/09/2023 DR-605/2023-2024 Note: - i. ISIN No. INE549S01010 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 01/09/2023. ii. The new ISIN Number for Rs. 5/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 09.08.2023) In Continuation of Notice No. 20230809-44 dated August 09, 2023, Trading Members of the Exchange are hereby informed that the New ISIN number for the Sub-Divided Equity Shares of the Company will be as under: - Company Name & Scrip Code REMEDIUM LIFECARE LTD (539561) New ISIN No. INE549S01028 Remarks Sub-division of equity shares from Rs.10/- to Rs.5/- The new ISIN number given above, for Equity Shares of Rs.5/- each of the Company shall be effective for trades done on and from the Ex-Date i.e. 01-09-2023 (DR-605/2023-2024) (As Per BSE Notice Dated on 23.08.2023)

Remedium Life: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.